Human Immunodeficiency virus type 2 (HIV-2) represents one of two major classes of human lentiviruses causing Acquired Immunodeficiency Syndrome (AIDS) in man. Although genetically and biologically related to HIV-1, HIV-2 possesses a number of properties that distinguish it from HIV-1 and make it a particularly attractive target for molecular studies of HIV biology and pathogenesis. These include a close genetic and epidemiologic relationship to a non-pathogenic simian lentivirus infecting feral sooty mangabeys in West Africa, virulence properties ranging from relative attenuation in certain human populations to high level pathogenicity in others, and the availability of an animal model system (macaques) for the evaluation of molecular determinants of viral pathogenicity. In this renewal application, we propose to systematically evaluate the molecular basis for attenuated virulence which we have identified in strains of HIV-2 infecting healthy individuals from rural or remote rural parts of West Africa. Functional analyses of genes and regulatory regions amplified directly from infected primary (uncultured) patient material will allow us to determine whether such viruses differ from prototypic strains in their fundamental viral properties and whether such viruses represent HIV-2 substrains with significantly reduced pathogenic potential.
Specific aims of the project are: 1. To employ nested PCR techniques to amplify and characterize individual HIV-2 genes and regulatory regions directly from uncultured PBMC DNA of healthy individuals from whom virus isolation has been repeatedly unsuccessful. 2. To use chimeric proviral constructs to functionally analyze the biologic activity of such genes and regulatory regions upon infection of natural target cells in vitro. 3. To utilize recombinant vaccinia virus expression systems to evaluate independently the structure/function relationships of envelope glycoproteins from """"""""culture-resistant"""""""" viruses, to determine whether they are deficient in processing, transport or cell surface expression, to test the extent of their cytopathic and fusogenic potential, and to determine their CD4 binding affinity. 4. To functionally analyze the reverse transcriptase of HIV-2 strains characterized by G to A hypermutation, to determine the genetic mechanisms responsible for this hypermutation, and evaluate its biological significance and role in the natural history of HIV-2 infection. 5. To obtain and characterize additional field strains of HIV-2 to confirm the validity of findings made in aims 1-4 and to obtain, by a similar approach, field strains of HIV-1 from remote African jungle areas for similar evaluation. From these studies, we expect to identify clinically important virologic determinants of HIV pathogenesis and insights into factors associated with the recent transmission of these viruses from simian species to man.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI025291-07
Application #
2062942
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Project Start
1987-09-30
Project End
1997-11-30
Budget Start
1993-12-01
Budget End
1994-11-30
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Gao, F; Robertson, D L; Carruthers, C D et al. (1998) A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 72:5680-98
Gao, F; Robertson, D L; Carruthers, C D et al. (1998) An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I). J Virol 72:10234-41
Owen, S M; Ellenberger, D; Rayfield, M et al. (1998) Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J Virol 72:5425-32
Georges-Courbot, M C; Lu, C Y; Makuwa, M et al. (1998) Natural infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus. J Virol 72:600-8
Salminen, M O; Carr, J K; Robertson, D L et al. (1997) Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol 71:2647-55
Stivahtis, G L; Soares, M A; Vodicka, M A et al. (1997) Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J Virol 71:4331-8
Su, L; Kaneshima, H; Bonyhadi, M L et al. (1997) Identification of HIV-1 determinants for replication in vivo. Virology 227:45-52
Gao, F; Robertson, D L; Morrison, S G et al. (1996) The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 70:7013-29
Gao, F; Morrison, S G; Robertson, D L et al. (1996) Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. J Virol 70:1651-67
Robertson, D L; Hahn, B H; Sharp, P M (1995) Recombination in AIDS viruses. J Mol Evol 40:249-59

Showing the most recent 10 out of 13 publications